PHILADELPHIA — (Feb 27, 2024) — The Wistar Institute, a global leader in biomedical research in cancer, immunology and infectious disease, is pleased to welcome Max Berger to its Board of Trustees.&n…
PHILADELPHIA—(Feb. 21, 2024)—The Wistar Institute’s associate professor Mohamed Abdel-Mohsen, Ph.D., has demonstrated, with his lab and collaborators, a connection between viral damage to the gut and…
Wistar scientist joins faculty to pursue research in breast and brain cancers PHILADELPHIA—(Feb. 13, 2024)— The Wistar Institute, an international biomedical research leader in cancer, infectious dis…
PHILADELPHIA (January 17, 2024) – The West Philadelphia Skills Initiative and The Wistar Institute are collaborating once again with support from the Philadelphia Industrial Development Corporation a…
PHILADELPHIA—(Dec. 18, 2023)—The Wistar Institute, a global leader in biomedical research in cancer, immunology and infectious disease, is pleased to welcome Aleister Saunders, Ph.D., and Patrick Oat…
PHILADELPHIA—(Dec. 13, 2023)— The Wistar Institute, an international biomedical research leader in cancer, infectious disease, immunology, and vaccine development, is pleased to announce the recruitm…
PHILADELPHIA—(Dec. 13, 2023)—Wistar researchers successfully tested a simple intervention that could unlock greater anti-tumor power in therapies that use T cells — an approach known as “cell-based t…
PHILADELPHIA—(Dec. 5, 2023)—Wistar scientists have developed a new tool that can help identify cancer-associated microbes by using machine learning technology. Under the leadership of Dr. Noam Auslan…
PHILADELPHIA—(Nov. 1, 2023)— The Wistar Institute’s David B. Weiner, Ph.D., executive vice president, director of the Vaccine & Immunotherapy Center (VIC) and W.W. Smith Charitable Trust Distingu…
PHILADELPHIA (October 17, 2023) – The Wistar Institute, a global leader in biomedical research in cancer, immunology and infectious diseases, announces the appointment of Dean Stoios as Chief Financi…
